VRTX

Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
$476.31
-3.94 (-0.82%)
Mkt Cap: 120.89B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield2.8%
Dividend YieldN/A
Market Cap120.89B
Volume1.09M
Recent News
Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals
fool.com · 2026-07-14
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors
zacks.com · 2026-07-13
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?
fool.com · 2026-07-13
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
marketbeat.com · 2026-07-11
Is This Biotech Stock a Buy Near Its 52-Week High?
fool.com · 2026-07-10
Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?
fool.com · 2026-07-10

Unlock the Full Deep Scan

9 AI agents analyze VRTX across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →